Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic resection with perioperative off-label Propranolol and Etodolac
DRKS00014054Phase 2Terminated
- Sponsor
- Heidelberg University Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pancreatic cancer (PC) comparing Propranolol + Etodolac with Placebo (2 arms). Started Aug 2018; status: terminated.
02
Drugs
propranololetodolac
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on DRKS00014054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014054.